These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
417 related items for PubMed ID: 12635926
21. MAIT cells launch a rapid, robust and distinct hyperinflammatory response to bacterial superantigens and quickly acquire an anergic phenotype that impedes their cognate antimicrobial function: Defining a novel mechanism of superantigen-induced immunopathology and immunosuppression. Shaler CR, Choi J, Rudak PT, Memarnejadian A, Szabo PA, Tun-Abraham ME, Rossjohn J, Corbett AJ, McCluskey J, McCormick JK, Lantz O, Hernandez-Alejandro R, Haeryfar SMM. PLoS Biol; 2017 Jun; 15(6):e2001930. PubMed ID: 28632753 [Abstract] [Full Text] [Related]
25. Superantigen antagonist protects against lethal shock and defines a new domain for T-cell activation. Arad G, Levy R, Hillman D, Kaempfer R. Nat Med; 2000 Apr; 6(4):414-21. PubMed ID: 10742148 [Abstract] [Full Text] [Related]
28. Streptococcus pyogenes: Insight into the function of the streptococcal superantigens. Sriskandan S, Faulkner L, Hopkins P. Int J Biochem Cell Biol; 2007 Apr; 39(1):12-9. PubMed ID: 17029999 [Abstract] [Full Text] [Related]
29. The TCR Vbeta signature of bacterial superantigens spreads with stimulus strength. Llewelyn M, Sriskandan S, Terrazzini N, Cohen J, Altmann DM. Int Immunol; 2006 Oct; 18(10):1433-41. PubMed ID: 16893924 [Abstract] [Full Text] [Related]
30. Lethal shock induced by streptococcal pyrogenic exotoxin A in mice transgenic for human leukocyte antigen-DQ8 and human CD4 receptors: implications for development of vaccines and therapeutics. Welcher BC, Carra JH, DaSilva L, Hanson J, David CS, Aman MJ, Bavari S. J Infect Dis; 2002 Aug 15; 186(4):501-10. PubMed ID: 12195377 [Abstract] [Full Text] [Related]
31. Binding of natural variants of staphylococcal superantigens SEG and SEI to TCR and MHC class II molecule. Fernández MM, De Marzi MC, Berguer P, Burzyn D, Langley RJ, Piazzon I, Mariuzza RA, Malchiodi EL. Mol Immunol; 2006 Mar 15; 43(7):927-38. PubMed ID: 16023209 [Abstract] [Full Text] [Related]
35. A new closed-tube multiplex real-time PCR to detect eleven superantigens of Streptococcus pyogenes identifies a strain without superantigen activity. Lintges M, Arlt S, Uciechowski P, Plümäkers B, Reinert RR, Al-Lahham A, Lütticken R, Rink L. Int J Med Microbiol; 2007 Oct 15; 297(6):471-8. PubMed ID: 17481952 [Abstract] [Full Text] [Related]
36. A novel superantigen isolated from pathogenic strains of Streptococcus pyogenes with aminoterminal homology to staphylococcal enterotoxins B and C. Mollick JA, Miller GG, Musser JM, Cook RG, Grossman D, Rich RR. J Clin Invest; 1993 Aug 15; 92(2):710-9. PubMed ID: 8349810 [Abstract] [Full Text] [Related]
37. Analysis of superantigenic toxin Vbeta T-cell signatures produced during cases of staphylococcal toxic shock syndrome and septic shock. Ferry T, Thomas D, Perpoint T, Lina G, Monneret G, Mohammedi I, Chidiac C, Peyramond D, Vandenesch F, Etienne J. Clin Microbiol Infect; 2008 Jun 15; 14(6):546-54. PubMed ID: 18373692 [Abstract] [Full Text] [Related]
38. Human scFvs That Counteract Bioactivities of Staphylococcus aureus TSST-1. Rukkawattanakul T, Sookrung N, Seesuay W, Onlamoon N, Diraphat P, Chaicumpa W, Indrawattana N. Toxins (Basel); 2017 Feb 17; 9(2):. PubMed ID: 28218671 [Abstract] [Full Text] [Related]
39. Defense against biologic warfare with superantigen toxins. Kaempfer R, Arad G, Levy R, Hillman D. Isr Med Assoc J; 2002 Jul 17; 4(7):520-3. PubMed ID: 12120463 [Abstract] [Full Text] [Related]
40. The bacterial superantigen streptococcal mitogenic exotoxin Z is the major immunoactive agent of Streptococcus pyogenes. Unnikrishnan M, Altmann DM, Proft T, Wahid F, Cohen J, Fraser JD, Sriskandan S. J Immunol; 2002 Sep 01; 169(5):2561-9. PubMed ID: 12193726 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]